COVID-19 live updates: Pfizer submits kids vaccine emergency use authorization request to FDA

(NEW YORK) — The United States has been facing a COVID-19 surge as the more contagious delta variant continues to spread.

More than 707,000 Americans have died from COVID-19 while over 4.8 million people have died from the disease worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.

Just 65.7% of Americans ages 12 and up are fully vaccinated against COVID-19, according to data from the CDC.

Here’s how the news is developing. All times Eastern:

Oct 07, 9:00 am

United expects travel surge in December

United Airlines expects a travel surge and plans to fly 3,500 daily domestic flights in December, making it the largest schedule since the start of the pandemic.

Flight searches for the holidays are up 16% on the airline’s website and app compared to 2019.

Florida and ski resorts are expected to be the hottest destinations.

Oct 07, 8:20 am

Pfizer submits kids vaccine emergency use authorization request to FDA

Pfizer has submitted an emergency use authorization to the FDA for use of its vaccine in children ages 5 to 11.

The FDA will have a public hearing on Oct. 26.

Shots for children 5 to 11 may be available by early November.

Oct 06, 5:59 pm

New rapid test to cost less than $10

The planned retail cost for the newly approved over-the-counter rapid home COVID-19 test, “Flowflex,” will be “less than $10 per test,” White House COVID-19 Response Coordinator Jeff Zients said at Wednesday’s briefing

ACON, the manufacturers of Flowflex, confirmed with ABC News that the White House’s statement is in line with their current estimated pricing.

The company told ABC News their goal when creating the at-home test was to make it, “more accessible and more affordable than the other over-the-counter tests in the market.”

By comparison the two rapid test kits currently out on the market –Abbott’s BinaxNow and Quidel’s Quickvue– each retail for $23.99.

Both BinaxNow and Quickvue kits come two tests, so that a person can test themselves twice over the course of a couple days. That means each individual test costs around $12 each.